DAIICHI SANKYO and Eli Lilly and Company


LONDON - Britons First to Benefit From Latest Heart Tablet Prasugrel (Efient(R) Black Triangle Drug) UK patients are the first to benefit from the launch of a new heart drug prasugrel (Efient), following authorisation by the European Medicines Agency (EMEA).
Older News
S M T W T F S
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2010 The Gaea Times